Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,546
Recruiting: 1,932
Ph III recruiting: 225
Growth YoY: +16.4%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 201–228 of 228 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00072540	S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix	withdrawn	Phase 2	0	SWOG Cancer Research NetworkNETWORK	0	Nov 8, 2013	clinicaltrials
NCT01481233	Oral Colchicine in Men With Castrate Resistant Prostate Cancer	withdrawn	Phase 2	0	Milton S. Hershey Medical CenterOTHER	0	Sep 27, 2013	clinicaltrials